Additive endocrine therapy for advanced breast cancer – back to the future (original) (raw)

Endocrine therapy for breast cancer

C. Heldermon

Update on Cancer Therapeutics, 2006

View PDFchevron_right

Endocrine Treatment of Breast Cancer: Current Perspectives, Future Directions

Tazia Irfan, Mainul Haque

View PDFchevron_right

Current status of endocrine therapy for breast cancer

Tetsuya Taguchi

Breast Cancer, 2003

View PDFchevron_right

Adjuvant endocrine therapy for postmenopausal breast cancer in the era of aromatase inhibitors: an update

Isabella Karat

International seminars in surgical oncology : ISSO, 2006

View PDFchevron_right

Recent advances in endocrine therapy of breast cancer

Anthony Howell

BMJ, 1997

View PDFchevron_right

Endocrine therapy of breast cancer

G. Luisetto

Annals of Oncology, 2002

View PDFchevron_right

Where do selective estrogen receptor modulators (SERMs) and aromatase inhibitors (AIs) now fit into breast cancer treatment algorithms?

Anthony Howell

The Journal of Steroid Biochemistry and Molecular Biology, 2001

View PDFchevron_right

Challenges in the endocrine management of breast cancer

Carsten Rose

The Breast, 2003

View PDFchevron_right

High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy

Per Lønning

Breast Cancer Research and Treatment, 2001

View PDFchevron_right

Mechanisms of action of endocrine treatment in breast cancer

Ernst Lien, Per Lønning

Critical Reviews in Oncology/Hematology, 1995

View PDFchevron_right

Third-generation aromatase inhibitors in the treatment of advanced breast cancer

Jean-Marc Nabholtz

Breast Cancer, 2001

View PDFchevron_right

Evolution of endocrine adjuvant therapy for early breast cancer

Per Lønning

Expert Opinion on Investigational Drugs, 2010

View PDFchevron_right

Breast cancer: Current and future endocrine therapies

Adam Januszewski

2014

View PDFchevron_right

Endocrine Therapy of Advanced Breast Cancer

Carsten Rose

Acta Oncologica, 1988

View PDFchevron_right

New endocrine therapies for breast cancer

Anthony Howell

European Journal of Cancer, 1996

View PDFchevron_right

Extended Adjuvant Endocrine Therapy in Breast Cancer: Current Status and Future Directions

Marcel Jinih

Clinical Cancer Updates, 2008

View PDFchevron_right

Lower-Dose vs High-Dose Oral Estradiol Therapy of Hormone Receptor–Positive, Aromatase Inhibitor–Resistant Advanced Breast Cancer

Donna Jeffe

JAMA, 2009

View PDFchevron_right

[Neoadjuvant endocrine therapy for locally advanced breast cancer]

Domenico Sergi

La Clinica terapeutica

View PDFchevron_right

Aromatase Inhibitors in advanced breast cancer

Marilynne N Kirshbaum

2010

View PDFchevron_right

The sequential use of endocrine treatment for advanced breast cancer: where are we?

M. Gnant

Annals of Oncology, 2012

View PDFchevron_right

Endocrinology and hormone therapy in breast cancer: aromatase inhibitors versus antioestrogens

Anthony Howell

Breast cancer research : BCR, 2004

View PDFchevron_right

Aromatase inhibitors in breast cancer

Stephen Hiscox

The American Journal of Geriatric Pharmacotherapy, 2004

View PDFchevron_right

Profound suppression of plasma estrogens by megestrol acetate in postmenopausal breast cancer patients

Steinar Lundgren

Clinical cancer research : an official journal of the American Association for Cancer Research, 1996

View PDFchevron_right

A randomised trial comparing two doses of the new selective aromatase inhibitor anastrozole (Arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancer

Anthony Howell

European Journal of Cancer, 1996

View PDFchevron_right

Role of aromatase inhibitors in the upfront adjuvant hormonal therapy of postmenopausal patients with breast cancer

Jean-Marc Nabholtz

Indian Journal of Surgical Oncology, 2010

View PDFchevron_right

Combined chemo-endocrine adjuvant therapy for patients with operable breast cancer: still a question?

Olivia Pagani

1998

View PDFchevron_right

Effect of Targeted Agents on the Endocrine Response of Breast Cancer in the Neoadjuvant Setting: A Systematic Review

Nicola Tinari

Journal of Cancer, 2015

View PDFchevron_right

Neoadjuvant endocrine therapy for breast cancer: past, present and future

Miguel Gil

Anti-Cancer Drugs, 2008

View PDFchevron_right

Aromatase inhibitors and their future role in post-menopausal women with early breast cancer

Per Lønning

British journal of cancer, 1998

View PDFchevron_right

Endocrine Therapy, New Biologicals, and New Study Designs for Presurgical Studies in Breast Cancer

Anita Dunbier

JNCI Monographs, 2011

View PDFchevron_right

Aromatase inhibitors in the treatment of early and advanced breast cancer

Lars Rutqvist

Acta Oncologica, 2005

View PDFchevron_right

Current concepts in the endocrine therapy of breast cancer: tamoxifen and aromatase inhibitors

Gurpreet Singh-ranger

Journal of Clinical Pharmacy and Therapeutics, 2005

View PDFchevron_right

New Endocrine Drugs for Treatment of Advanced Breast Cancer

Per Lønning

Acta Oncologica, 1990

View PDFchevron_right

Clinical breast cancer, new developments in selection and endocrine treatment of patients

Marcel Bontenbal

The Journal of Steroid Biochemistry and Molecular Biology, 1992

View PDFchevron_right